99 related articles for article (PubMed ID: 11998714)
1. [Factors contributing to interindividual variability to chemical toxicity].
Lindeman B; Søderlund EJ; Dybing E
Tidsskr Nor Laegeforen; 2002 Feb; 122(6):615-8. PubMed ID: 11998714
[TBL] [Abstract][Full Text] [Related]
2. Situations with enhanced chemical risks due to toxicokinetic and toxicodynamic factors.
Dybing E; Søderlund EJ
Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S27-30. PubMed ID: 10597610
[TBL] [Abstract][Full Text] [Related]
3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
4. Assessment factors--applications in health risk assessment of chemicals.
Falk-Filipsson A; Hanberg A; Victorin K; Warholm M; Wallén M
Environ Res; 2007 May; 104(1):108-27. PubMed ID: 17166493
[TBL] [Abstract][Full Text] [Related]
5. [Pharmacogenetics: pharmacokinetics and clinical implications].
Blardi P
Recenti Prog Med; 1997 Jan; 88(1):46-55. PubMed ID: 9102716
[TBL] [Abstract][Full Text] [Related]
6. Human variability in hepatic and renal elimination: implications for risk assessment.
Dorne JL
J Appl Toxicol; 2007; 27(5):411-20. PubMed ID: 17497760
[TBL] [Abstract][Full Text] [Related]
7. Health-related disparities: influence of environmental factors.
Olden K; White SL
Med Clin North Am; 2005 Jul; 89(4):721-38. PubMed ID: 15925646
[TBL] [Abstract][Full Text] [Related]
8. Impact of inter-individual differences in drug metabolism and pharmacokinetics on safety evaluation.
Dorne JL
Fundam Clin Pharmacol; 2004 Dec; 18(6):609-20. PubMed ID: 15548231
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenomics: state of the research and perspectives in clinical application.
Severino G; Chillotti C; Stochino ME; Del Zompo M
Neurol Sci; 2003 May; 24 Suppl 2():S146-8. PubMed ID: 12811615
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of toxicant response: sources of human variability.
Aldridge JE; Gibbons JA; Flaherty MM; Kreider ML; Romano JA; Levin ED
Toxicol Sci; 2003 Nov; 76(1):3-20. PubMed ID: 12883075
[TBL] [Abstract][Full Text] [Related]
11. The emerging field of ecogenetics.
Costa LG
Neurotoxicology; 2000; 21(1-2):85-9. PubMed ID: 10794388
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics in HIV therapy.
Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
[TBL] [Abstract][Full Text] [Related]
13. Combinatorial pharmacogenetics.
Wilke RA; Reif DM; Moore JH
Nat Rev Drug Discov; 2005 Nov; 4(11):911-8. PubMed ID: 16264434
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
15. Children as a sensitive subgroup and their role in regulatory toxicology: DGPT workshop report.
Schwenk M; Gundert-Remy U; Heinemeyer G; Olejniczak K; Stahlmann R; Kaufmann W; Bolt HM; Greim H; von Keutz E; Gelbke HP;
Arch Toxicol; 2003 Jan; 77(1):2-6. PubMed ID: 12491033
[TBL] [Abstract][Full Text] [Related]
16. Individualized medicine - implementation of pharmacogenetic diagnostics in antidepressant drug treatment of major depressive disorders.
Kirchheiner J; Bertilsson L; Bruus H; Wolff A; Roots I; Bauer M
Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S235-43. PubMed ID: 14677085
[TBL] [Abstract][Full Text] [Related]
17. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
Brent RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
[TBL] [Abstract][Full Text] [Related]
18. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
19. Impact of pharmacogenetics on toxicological studies. Statistical implications.
Lovell DP
J Exp Anim Sci; 1993 Sep; 35(5-6):259-81. PubMed ID: 8218441
[TBL] [Abstract][Full Text] [Related]
20. Clinical application of pharmacogenetics in gastrointestinal diseases.
Saito YA; Camilleri M
Expert Opin Pharmacother; 2006 Oct; 7(14):1857-69. PubMed ID: 17020413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
